Literature DB >> 23151897

Adalimumab-induced psoriasis in a patient with Crohn's disease.

Ugur Korkmaz, Ali Erkan Duman, Gokhan Dindar, Hasan Yilmaz, Ibrahim Hakki Dursun, Altay Celebi, Omer Senturk, Sadettin Hulagu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23151897     DOI： 10.1007/s12664-012-0281-2

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN： 0254-8860


× No keyword cloud information.
  9 in total

1.  A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agents.

Authors:  C Ritchlin; F Tausk
Journal:  Ann Rheum Dis       Date:  2006-12       Impact factor: 19.103

2.  Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: the Mayo Clinic experience, 1998 to 2010.

Authors:  Eugenia Shmidt; David A Wetter; Sara B Ferguson; Mark R Pittelkow
Journal:  J Am Acad Dermatol       Date:  2011-07-14       Impact factor: 11.527

3.  Palmoplantar psoriasis: a paradoxical adverse reaction induced by adalimumab.

Authors:  M T Bordel-Gómez; J Sánchez-Estella; O Martínez-González; Maria E Cardeñoso-Alvarez
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-07-03       Impact factor: 6.166

4.  Resolution of adalimumab-induced psoriasis after vitamin D deficiency treatment.

Authors:  Gláucio Ricardo Werner de Castro; Fabrício Souza Neves; Ivanio Alves Pereira; Sonia Cristina Magalhaes Souza Fialho; Giovana Ribeiro; Adriana Fontes Zimmermann
Journal:  Rheumatol Int       Date:  2011-02-03       Impact factor: 2.631

Review 5.  TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.

Authors:  Anne-Marie Tobin; Brian Kirby
Journal:  BioDrugs       Date:  2005       Impact factor: 5.807

Review 6.  Biology of tumor necrosis factor-alpha- implications for psoriasis.

Authors:  Arndt J G Schottelius; Lyle L Moldawer; Charles A Dinarello; Khusru Asadullah; Wolfram Sterry; Carl K Edwards
Journal:  Exp Dermatol       Date:  2004-04       Impact factor: 3.960

Review 7.  Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action.

Authors:  Angelique N Collamer; Karen T Guerrero; Jeffery S Henning; Daniel F Battafarano
Journal:  Arthritis Rheum       Date:  2008-07-15

Review 8.  Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases.

Authors:  Justin M Ko; Alice B Gottlieb; Joseph F Kerbleski
Journal:  J Dermatolog Treat       Date:  2009       Impact factor: 3.359

9.  Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.

Authors:  Morad Lahfa; Ulrich Mrowietz; Miriam Koenig; Jan C Simon
Journal:  Eur J Dermatol       Date:  2003 May-Jun       Impact factor: 3.328
  9 in total
  1 in total

1.  Cell-type-restricted anti-cytokine therapy: TNF inhibition from one pathogenic source.

Authors:  Grigory A Efimov; Andrei A Kruglov; Zoya V Khlopchatnikova; Fedor N Rozov; Vladislav V Mokhonov; Stefan Rose-John; Jürgen Scheller; Siamon Gordon; Martin Stacey; Marina S Drutskaya; Sergei V Tillib; Sergei A Nedospasov
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-02       Impact factor: 11.205
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.